Targeting EZH2 and EGFR therapeutic vulnerabilities of TNBC with a single chemical entity confers preclinical treatment advantage

Neural Networks · Elsevier

Аннотация

Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Saumya Ranjan Satrusal, Arpita Banerjee, Arpon Biswas, Gaurava Srivastava, Indranil Chatterjee, Muqtada Ali Khan, Biswajit Mandal, Kiran Tripathi, Abhipsa Sinha, Ayushi Verma, Priyanka Rai, Mahmood Akbar, Shivansh Kumar, Sohini Chatterjee, Kulranjan Singh, Aamir Nazir, Rabi Sankar Bhatta, Gautam Panda, Dipak Datta

Читать у издателя →

Похожие статьи